2018
DOI: 10.4183/aeb.2018.570
|View full text |Cite
|
Sign up to set email alerts
|

Pheochromocytoma-Paraganglioma: Translational Approach from Genetics to Clinical Neuroendocrinology

Abstract: In the latest decade, translational medicine has played an important role. In neuroendocrine tumor field, genetic results are associated with clinical and paraclinical disease implications. This translational knowledge allows a faster action in some mutation types with aggressive outcome. In the following pages we will make a review about actualities in translational approach from genetics to clinical neuroendocrinology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Extensive genetic research over the past decade revealed new pheochromocytoma susceptibility genes, so at present familial forms are estimated to be almost 40% (29). Uncommon clinical presentation or biochemical profile as well as unusual comorbidities in patients with PPGL may open a window to new discoveries in the field of genetics of this rare tumor (29,34,41).…”
Section: Discussionmentioning
confidence: 99%
“…Extensive genetic research over the past decade revealed new pheochromocytoma susceptibility genes, so at present familial forms are estimated to be almost 40% (29). Uncommon clinical presentation or biochemical profile as well as unusual comorbidities in patients with PPGL may open a window to new discoveries in the field of genetics of this rare tumor (29,34,41).…”
Section: Discussionmentioning
confidence: 99%